高级检索
当前位置: 首页 > 详情页

microRNA-150 promotes cervical cancer cell growth and survival by targeting FOXO4.

文献详情

资源类型:
Pubmed体系:
机构: [1]Department of Obstetrics and Gynecology, The Second Affiliated Hospital, Chongqing Medical University, Linjiang Road 76, Chongqing 400010, People’s Republic of China [2]Department of Obstetrics and Gynecology, The Second Clinical Medical Institute of North Sichuan Medical College, Nanchong 637000, Sichuan, People’s Republic of China.
出处:

关键词: Cervical cancer miR-150 FOXO4 Apoptosis Cell cycle

摘要:
Dysregulation of microRNA-150 (miR-150) is commonly observed in solid tumor and has been reported to be involved in multiple important biological processes, such as cell proliferation, apoptosis, and metastasis. Elevated miR-150 level was also detected in cervical carcinoma, whereas its function in cancer progression has not been studied yet. The expression of miRNA-150 in cervical carcinoma was compared with normal cervical tissue and using qRT-PCR. The effects of miR-150 on cell cycle and apoptosis, as well as the expression of cycle- and apoptosis-related genes, were determined using flow cytometry, TUNEL assay, qRT-PCR, and Western blot, respectively. The direct target of miR-150 was confirmed using 3' untranslated region (UTR) luciferase reporter assay. miR-150 promotes cervical cancer cell survival and growth, while the inhibition of miR-150 suppresses these actions. miR-150 also induced the cell cycle progression from G1/G0 to S phase, resulting in an enhancement of growth. Several cell cycle- and apoptosis-related genes, CyclinD1, p27, BIM, and FASL were modulated by miR-150. Moreover, miR-150 directly reduced the expression of FOXO4, which regulates the expression of CyclinD1, p27, BIM, and FASL, by targeting its 3' UTR. Taken together, our data demonstrated that elevated miR-150 targets FOXO4 expression and therefore regulates multiple genes expression, resulting in cervical cancer cell growth and survival.

语种:
PubmedID:
中科院(CAS)分区:
出版当年[2015]版:
大类 | 3 区 生物
小类 | 4 区 生化与分子生物学
最新[2023]版:
第一作者:
第一作者机构: [1]Department of Obstetrics and Gynecology, The Second Affiliated Hospital, Chongqing Medical University, Linjiang Road 76, Chongqing 400010, People’s Republic of China [2]Department of Obstetrics and Gynecology, The Second Clinical Medical Institute of North Sichuan Medical College, Nanchong 637000, Sichuan, People’s Republic of China.
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:46861 今日访问量:0 总访问量:3333 更新日期:2024-11-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号